ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Obesity"

  • 2020 American Transplant Congress

    Basiliximab Induction in the Obese: One Size Does Fit All

    A. D. Reticker1, D. Choi1, A. B. Lichvar1, C. Kane2, I. Tzvetanov3, E. Benedetti3, J. J. Benken1

    1Pharmacy Practice, University of Illinois Hospital and Health Sciences System, Chicago, IL, 2Pharmacy, Northwestern Memorial Hospital, Chicago, IL, 3Surgery, University of Illinois Hospital and Health Sciences System, Chicago, IL

    *Purpose: Surgical advancements allow more obese (BMI> 30 kg/m2) patients to receive a renal transplant. The original clinical and pharmacokinetic (PK) trials in transplantation immunosuppression…
  • 2020 American Transplant Congress

    Liver Transplant Recipients with BMI 40 to <50 kg/m2 Have Excellent Patient and Graft Survival

    K. Daniel, J. Hause, F. Osman, J. Mezrich, E. Spengler

    University of Wisconsin School of Medicine and Public Health, Madison, WI

    *Purpose: Obesity rates in the United States (US) have reached nearly 40%, which has led to an increasing proportion of liver transplant (LT) candidates with…
  • 2020 American Transplant Congress

    Sleeve Gastrectomy Compared with Gastric Bypass for Morbidly Obese Liver Transplant Candidates: A Decision Analysis

    R. A. Choudhury1, D. Yoeli1, G. Hoeltzel2, H. B. Moore1, H. Yaffe1, K. R. Dumon3, N. N. Williams3, P. L. Abt4, K. D. Conzen1, J. J. Pomposelli1, E. A. Pomfret1, T. L. Nydam1

    1Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, 2Thomas Jefferson University Hospital, Philadelphia, PA, 3Department of Surgery, University of Pennsylvania Hospital, Philadelphia, PA, 4Department of Surgery- Division of Transplantation Surgery, University of Pennsylvania Hospital, Philadelphia, PA

    *Purpose: The use of bariatric surgery has increased for morbidly obese liver transplant candidates for whom placement on the waitlist is often restricted until they…
  • 2020 American Transplant Congress

    Bariatric Surgery to Improve Candidacy for Kidney Transplantation: A Systematic Review and Meta-Analysis

    J. Purvis1, S. Mehta1, R. Stahl1, J. Grams1, M. Hanaway1, D. Anderson1, C. Young1, R. Cannon1, C. Lewis1, N. Terrault2, J. Locke1, B. Orandi1

    1University of Alabama at Birmingham, Birmingham, AL, 2University of Southern California, Los Angeles, CA

    *Purpose: There is a growing epidemic of obesity in patients with end stage kidney disease in need of kidney transplant, paralleling the general population. Most…
  • 2020 American Transplant Congress

    Challenges in Manufacturing Clinically Competent Regulatory T Cells from Obese Renal Transplant Recipients

    F. Marti, A. Ruffing, E. Chacon, L. Turcios, D. Valvi, J. Gonzalez, R. Gedaly

    Surgery, University of Kentucky, Lexington, KY

    *Purpose: The obesity epidemic has expanded rapidly over the last decade. Our program is developing a novel clinical protocol using expanded autologous regulatory T cell…
  • 2020 American Transplant Congress

    Readmission Outcomes of Bariatric Surgery in Liver Transplant Recipients

    R. A. Choudhury1, D. Yoeli1, H. Yaffe1, H. B. Moore1, G. Hoeltzel2, A. Schulick1, P. L. Abt3, K. Dumon4, K. D. Conzen1, J. J. Pomposelli1, E. A. Pomfret1, T. L. Nydam1

    1Department of Surgery- Division of Transplantation Surgery, University of Colorado Hospital, Aurora, CO, 2Thomas Jefferson University Hospital, Philadelphia, PA, 3Department of Surgery- Division of Transplantation Surgery, University of Pennsylvania Hospital, Philadelphia, PA, 4Department of Surgery, University of Pennsylvania Hospital, Philadelphia, PA

    *Purpose: Bariatric surgery has increasingly been offered for morbidly obese patients prior to liver transplantation with the hope of improving both waitlist candidacy and post-transplant…
  • 2020 American Transplant Congress

    The Impact of Increased Visceral Fat in Kidney Transplant Recipients

    Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika

    Ehime University, Toon, Japan

    *Purpose: An increased amount of visceral fat (VF) has been reported as a precursor to metabolic syndrome and is a risk factor for renal dysfunction.…
  • 2020 American Transplant Congress

    Rate of Change in Body Mass Index Prior to Liver Transplantation is Independently Associated with Post-Transplant Survival

    N. Mahmud1, Y. Saiman1, M. Serper1, E. Weinberg1, K. Rothstein1, D. Goldberg2

    1Hospital of the University of Pennsylvania, Philadelphia, PA, 2University of Miami, Miami, FL

    *Purpose: Patients at the extremes of body mass index (BMI) have poorer outcomes after liver transplantation (LT). Current national guidelines regard BMI ≥40 to be…
  • 2020 American Transplant Congress

    Effects of BMI on Kidney Transplant Outcomes are Highly Modified by Patient and Donor Characteristics

    J. Schold1, J. Augustine2, A. Huml2, R. Fatica2, S. Nurko2, A. Wee3, E. Poggio2

    1Cleveland Clinic Foundation, Cleveland, OH, 2Nephrology, Cleveland Clinic Foundation, Cleveland, OH, 3Surgery, Cleveland Clinic Foundation, Cleveland, OH

    *Purpose: Body Mass Index (BMI) is a well-established risk factor for transplant outcomes and high BMI is a commonly used relative contradiction for used for…
  • 2020 American Transplant Congress

    NASH is the Leading Indication for Liver Transplantation in Elderly Patients

    J. A. Steggerda1, J. Yang2, V. Sundaaram2, N. Alkouri3, W. Ayoub2, I. K. Kim1, M. Noureddin2

    1Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, 2Hepatology, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, 3Gastroenterology, University of Texas Health- San Antonio, San Antonio, TX

    *Purpose: Non-alcoholic steatohepatitis (NASH) is an increasingly prevalent cause of end-stage liver disease (ESLD) and indication for liver transplantation (LT) in the United States and…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 24
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences